跳至主要内容
临床试验/CTRI/2011/091/000222
CTRI/2011/091/000222已完成1 期

A Single Centre, Prospective, Randomized, Double-blind Placebo Controlled Study of Safety And Efficacy of KSM-66 in Healthy Adults.

Ixoreal Biomed Priavte Limited,#5-9-225, 3rd floor, Sanali estate, Chirag ali lane, Abids,Hyderabad, Andhra Pradesh- 500001, India0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ?Healthy adults of either sex, who are facing routine work stresses, who sign the Informed Consent Form.
  • ?Age group 18 -54 years
  • ?Can read , write and understand English
  • ?Subjects with WHO-5 well being index < 15 or PSS scores >14

排除标准

  • ?Suffering from any chronic physical, hormonal or psychiatric illness
  • ?Current substance dependence
  • ?Individuals refusing to use appropriate non-hormonal birth control measures.
  • ?Pregnancy / lactating mothers
  • ?Currently taking any other medication on a regular basis
  • ?Currently taking any herbal preparations (other formulations containing ashwagandha / ginseng / ginkgo biloba / brahmi etc)
  • ?Clinically significant findings on laboratory investigations and ECG

研究者

发起方
Ixoreal Biomed Priavte Limited,#5-9-225, 3rd floor, Sanali estate, Chirag ali lane, Abids,Hyderabad, Andhra Pradesh- 500001, India

相似试验

进行中(未招募)
1 期
A clinical study investigating the analgesic effects of Midazolam compared to an inactive substance (placebo) in human volunteer subjects with the use of Fentanyl as an active (i.e. analgesic) control substance whereby all participants receive all treatments.nociceptive pain
EUCTR2015-004097-15-ATWilhelminenspital
招募中
不适用
Efficacy of Heat-Killed Bifidobacterium supplementation in patients of sarcopenia
JPRN-jRCTs031200200Asaoka Daisuke100
进行中(未招募)
1 期
A single center randomised placebo controlled study to test a novel topical formulation containing Niclosamide, an antibiotic.AntibioTx has developed a topical product (ATx201) for treatment of infected eczema and infected atopic dermatitis. These infections are predominantly caused by Staphyllococcus aureus and various species of Streptococcus. Treatment of these infections is plagued by inactivity of or resistance towards the main topical antibiotics (fucidic acid, mupirocin and retapamulin).MedDRA version: 20.0Level: HLTClassification code 10040788Term: Skin and subcutaneous tissue bacterial infectionsSystem Organ Class: 100000004858
EUCTR2016-003501-33-ATAntibioTx ApS76
已完成
不适用
A single centre, prospective, randomised, double-blind, placebo controlled, sequential, dose-escalating phase I study to assess the safety and tolerability of intravenously infused single doses of OPN-305 in healthy subjects.inflammatory reactionsrejections10038365
NL-OMON38332Opsona Therapeutics Ltd.50
已完成
不适用
Prospective, single-center, randomized, double-blind, placebo-controlled, two-part Phase 1 study to assess the effect of single therapeutic and supra-therapeutic doses of lucerastat on the QT/QTc interval duration in healthy subjectsFabry diseaseLysosomal storage disease
NL-OMON48323Idorsia Pharmaceuticals Ltd44